•  
  • New York 21:16
  • London 01:16
  • Barcelona 02:16
  • Tokyo 10:16
  • Sydney 12:16
  • SignUp | Login

Daily Options Intelligence Report

Rise in pain treatment sales delivers options gains for investor at Endo

Thu, Jul 30 2009, 16:49 GMT
by Andrew Wilkinson

Interactive Brokers LLC  |  View company's profile


Vote:

0

0

ENDP – Endo Pharmaceuticals Holdings, Inc. – The pharmaceutical company edged onto our ‘hot by options volume’ market scanner after one option trader ramped up a bullish position on the stock. Shares of ENDP are currently higher by more than 2.5% to $20.84 on reports that the firm increased sales of key pain treatments in the second-quarter. It appears that the investor originally scooped up bullish call options on July 1, 2009, when he paid an average premium of 1.19 apiece for 3,500 lots at the August 17.5 strike price. The trader’s optimistic outlook for the firm was rewarded today when he sold the 3,500 calls for a premium of 3.50 per contract. The investor reeled in profits of about 2.31 each, a total of $808,500, by closing out the position. Finally, the same individual, hoping for continued bullish movement in shares, chose to reestablish a 3,500-lot long call position at the now in-the-money September 20 strike for 1.85 each. The investor will begin to amass profits on the new position if shares rise 5% higher and surpass the breakeven point at $21.85 by expiration.

ABC – AmerisourceBergen Corp. – Shares at the drug wholesale tore away in Wednesday’s session ahead of Thursday’s earnings, which in the event did beat expectations and investors taking profits. Option implied volatility slumped 25% leading to lower premiums on both puts and calls while its share price eased to $20.12. Option sellers appeared to close bearish plays at next month’s expiry targeting the 16 strike. Some 16,000 bear puts are currently open, while today’s volume at that strike indicated around half of these may have been sold at losses at an average premium of 7.5 cents. The company indicated revenues later this year should be higher rather than lower then earlier estimates leaving $21.72 marking the next target for bulls, the 52-week high from last August. Option implied volatility came into 29%. August call options felt the brunt of the volatility collapse today. One option investor traded a block of 5,400 calls at the 20 strike at an 80 cent premium while shares where at $20.37. The subsequent prick of the volatility bubble, perhaps coinciding with an 11am earnings conference call saw premiums decline with those same calls now trading at 50 cents.

GE – General Electric – A shift to “buy” from “neutral” from a Goldman Sachs analyst helped both shares in the industrial conglomerate and buoyed broader market sentiment. GE’s shares jumped 7% to $13.15 while option bulls were out in force as evidenced by the call to put ratio of 2.9 indicating almost tripe the appetite for bullish call strategies. The analyst predicted that GE’s health is good enough to allow it to maintain ownership of GE Capital and while that uncertainty provided near term relief, the future gauge of fear hardly budged with option implied volatility dropping from 40% to 39%. The heaviest tracked options activity showed up at the August expiration 14 strike calls where 48,000 lots changed hands at premiums ranging from 13 to 24 cents. As prices rose toward the top of that range throughout the morning on decent volume, one option investor sold a block of 12,000 contracts at a 20 cent premium. Prices have decayed further since that time. The current probability of landing in-the-money by August 21 expiration is just one-in-four. The odds of a move to $14.00 by September is 35%.

DOW – The Dow Chemical Company – The largest U.S. chemical maker has enjoyed a more than 8% rally in shares today to $21.95 after reporting second-quarter profits which exceeded analyst estimates. DOW posted earnings of 5 cents per share and surpassed average analyst expectations of a loss of 7 cents. Cost-cutting measures and improved sales volume for the quarter boosted the stock and prompted an analyst at Citigroup Global Markets to upgrade the shares to ‘buy’ from ‘hold’. Option traders hoping for continued upward movement in DOW targeted the near-term August 22 strike price where 2,200 calls were picked up for an average premium of 98 cents apiece. Investors will bank profits on the calls if shares can climb 5% higher to the breakeven point at $22.98 by expiration. Elsewhere, traders were seen locking in gains by purchasing protective put options in the September contract. Approximately 5,000 puts were purchased for 1.00 apiece at the September 21 strike price. Downside protection for these investors will kick in if shares slip beneath the breakeven point of $20.00 by expiration.


Archive


Legal disclaimer and risk disclosure

The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither Interactive Brokers LLC nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither IB nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance is not necessarily indicative of future results. This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only correct as of the stated date of their issue. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
Vote:

0

0


Note: All information on this page is subject to change. The use of this website constitutes acceptance of our user agreement. Please read our privacy policy and legal disclaimer.

Trading foreign exchange on margin carries a high level of risk and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to trade foreign exchange you should carefully consider your investment objectives, level of experience and risk appetite. The possibility exists that you could sustain a loss of some or all of your initial investment and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with foreign exchange trading and seek advice from an independent financial advisor if you have any doubts.

Opinions expressed at FXstreet.com are those of the individual authors and do not necessarily represent the opinion of FXstreet.com or its management. FXstreet.com has not verified the accuracy or basis-in-fact of any claim or statement made by any independent author: errors and Omissions may occur.

Any opinions, news, research, analyses, prices or other information contained on this website, by FXstreet.com, its employees, partners or contributors, is provided as general market commentary and does not constitute investment advice. FXstreet.com will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on such information.

©2010 "FXstreet.com. The Forex Market" All Rights Reserved.